News

ATRO Medical secures €3 million investment to advance Artimis® Meniscus Prosthesis | Alumni news (Venture Challenge Fall 2013)

ATRO Medical, alumnus of the Venture Challenge Fall 2013, has successfully closed a €3 million financing round supported by investors from the Netherlands, Switzerland and the United Arab Emirates.
https://www.linkedin.com/posts/atro-medical-bv_%F0%9D%90%88%F0%9D%90%A7%F0%9D%90%AF%F0%9D%90%9E%F0%9D%90%AC%F0%9D%90%AD%F0%9D%90%A6%F0%9D%90%9E%F0%9D%90%A7%F0%9D%90%AD-%F0%9D%90%AB%F0%9D%90%A8%F0%9D%90%AE%F0%9D%90%A7%F0%9D%90%9D-%F0%9D%90%9C%F0%9D%90%A5%F0%9D%90%A8-activity-7432092869789863937-CumB?utm_source=share&utm_medium=member_desktop&rcm=ACoAAC5oynoBUAn3wLyUzxN-synau9ZuiYrIpKk

Expert Class recap: navigating EU MDR with confidence

On 13 February 2026, LifeSciences@Work hosted an Expert Class at Axon Lawyers in Amsterdam, focused on navigating the European Medical Device Regulation (MDR) and related regulatory frameworks.
Expert class

Pre-announcement: Science for Industry Call 2026

Health~Holland will soon open the Science for Industry Call 2026, offering at least €5 million in PPP (public-private partnership) subsidy to support R&D collaborations within the Dutch Life Sciences & Health (LSH) sector.

Drug Repurposing Venture Challenge 2026: From breakthrough research to viable venture

ZonMw and FAST will organise the second edition of the Drug Repurposing Venture Challenge from June to October 2026.
VC

From Venture Challenge to First Funding: Omivera turns CellEKT into a new drug discovery venture

What does it take to turn years of academic research into a viable life sciences company? For Leiden-based startup Omivera, the answer started with the Venture Challenge program in the winter of 2025.
xx

Cyclomics raises €2.6 million to advance liquid biopsy diagnostics | Alumni news (Venture Challenge Fall 2017)

Cyclomics, alumnus of the Venture Challenge Fall 2017, has raised €2.6 million in new financing to support the further development and commercialisation of its liquid biopsy diagnostics for cancer detection.
Cyclomics raises €2.6 million to advance liquid biopsy diagnostics | Alumni news (Venture Challenge Fall 2017)

Sirius Medical obtains MDR CE-mark for Pintuition system | Alumni news (Venture Challenge Fall 2015)

Sirius Medical, alumnus of the Venture Challenge Fall 2015, has obtained MDR CE-marking for its Pintuition Surgical Marker Navigation System.
Sirius Medical obtains MDR CE-mark for Pintuition system | Alumni news (Venture Challenge Fall 2015)

Venture Challenge alumni awarded in NWO Take-off 2025

Several LifeSciences@Work alumni have been awarded funding in the 2025 NWO Take-off rounds, supporting the next steps in translating academic research into viable ventures.

ShanX Medtech secures €24 million to accelerate ultra-rapid antimicrobial susceptibility testing | Alumni news

ShanX Medtech B.V., alumni of the Venture Challenge Summer 2020, has secured a total of €24 million in financing to accelerate the final development, clinical validation, regulatory approval and commercial launch of its ultra-rapid antimicrobial susceptibil
ShanX Medtech secures €24 million to accelerate ultra-rapid antimicrobial susceptibility testing | Alumni news

Cyclomics Secures New Investment to Accelerate Commercialization of Ultra-Sensitive Cancer Diagnostics by Fast and High-Resolution DNA Sequencing Strategie

Cyclomics BV, a pioneer in liquid biopsy technology, announces the successful closing of a new investment round led by Myosotis Investments and supported by Oncode Bridge Fund. This